Go Reply and Sprint Reply Automate Clinical Study Report Generation for Dr. Willmar Schwabe Using AI In a groundbreaking collaboration, Go Reply, a leading Google Cloud Premier Partner, and Sprint Reply, the Reply Group’s expert in strategic consulting and digital…
New International Guidelines Released for the Treatment of Candida Fungal Infections A groundbreaking global guideline for the diagnosis and treatment of Candida infections has been published in The Lancet Infectious Diseases. This comprehensive guideline establishes new standards for the management…
Ventus Therapeutics Names Dr. Mona Kotecha as Chief Medical Officer Ventus Therapeutics, a clinical-stage biopharmaceutical company, has announced the appointment of Mona Kotecha, M.D., as its new Chief Medical Officer (CMO). Ventus is advancing two novel small-molecule programs, VENT-03 and…
Stablepharma Secures Prestigious €2.5 Million EIC Accelerator Grant, Recognised Among Europe’s Leading Innovators UK-based biotechnology company Stablepharma Ltd has secured €2.5 million in funding from the highly competitive European Innovation Council (EIC) Accelerator program. This significant achievement highlights the company’s…
GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance GeneDx Holdings Corp. (Nasdaq: WGS), a leader in leveraging genomic insights to drive improved health outcomes, has announced its financial results for the fourth quarter and…
Galderma’s Nemluvio® Approved in UK & Switzerland for Skin Conditions Galderma, a global leader in dermatology, has announced that its innovative monoclonal antibody treatment, Nemluvio® (nemolizumab), has been granted marketing authorization by both the United Kingdom’s Medicines and Healthcare products…
ICC Arbitral Tribunal Decides in Favor of AOP Health in Arbitration over BESREMi® (Ropeginterferon alfa-2b) A tribunal under the International Chamber of Commerce (ICC) issued a partial final award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its…
Breakthrough ‘Super Test’ for Prostate Cancer Developed by EDX Medical in the UK Scientists in Cambridge have unveiled a groundbreaking new diagnostic tool, hailed as a ‘super test’ for prostate cancer, with the potential to revolutionize screening, early detection, and…
FDA Grants Breakthrough Status to Innate Pharma’s Lacutamab for Sézary Syndrome Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) announced today that the U.S. FDA has granted Breakthrough Therapy Designation (BTD) to lacutamab, an anti-KIR3DL2 cytotoxicity-inducing…
U.S. FDA Fully Approves Deciphera’s ROMVIMZA™ for TGCT Treatment Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) has announced that the U.S. Food and Drug Administration (FDA) has granted full approval for ROMVIMZA™ (vimseltinib), a kinase inhibitor,…
European Commission Approves KOSTAIVE®, the First Self-Amplifying mRNA COVID-19 Vaccine Global biotechnology leader and self-amplifying mRNA (sa-mRNA) pioneer Arcturus Therapeutics (Nasdaq: ARCT) have announced that the European Commission (EC) has granted marketing authorization for KOSTAIVE® (ARCT-154), a breakthrough self-amplifying mRNA…
Tempus Partners with IFLI to Advance Development of Targeted Therapies for Follicular Lymphoma Tempus AI, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Join Forces to Accelerate Development of Targeted Therapies for Follicular Lymphoma Tempus AI, Inc., a pioneering…